rawfin.tv
Olema Pharmaceuticals Collaborates on Mammo 2026 Breast Cancer Congress
MarketsstocksAI Generated

Olema Pharmaceuticals Collaborates on Mammo 2026 Breast Cancer Congress

By rawfin.tv Markets Desk||Updated |1 min read|AI-assisted · Methodology

Olema Pharmaceuticals (OLMA) and OncoDaily are partnering to host Mammo 2026, a virtual global congress focused on breast cancer care. The collaboration aims to bring together diverse perspectives on advancements in breast cancer treatment and research.

OlemaPharmaceuticalsHealthcareBiotechnologyMedicalConferenceCancerResearch

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks